Principal Investigator Tampa Location:

Cynthia Huffman MD- Neurologist, board-certified by the American College of Psychiatry and Neurology. During her four years with Meridien Research, Dr. Cynthia Huffman has been a principal investigator and sub-investigator for over 100 clinical trials. Although, Dr. Huffman specializes in CNS trials, her broad range of investigation includes studies in multiple sclerosis, age associated memory impairment, mild cognitive impairment, generalized anxiety disorder, depression, post herpetic neuralgia, diabetic peripheral neuralgia, insomnia, Alzheimer’s disease, dermatology, gynecology, internal medicine, rheumatology, gastroenterology and endocrinology.

Dr. Huffman received her B.S. from Ohio State University and her M.D. from Wright State University. She did her four-year residency at the Texas Medical Center at Baylor College of Medicine in Houston. Dr. Huffman is board-certified by the American College of Psychiatry and Neurology since 1987.

In addition to the above, Dr. Huffman’s medical experience includes thirteen years in private practice serving out-patients, and hospital and rehabilitation patients. Dr. Huffman has been the director of a National Multiple Sclerosis Society sponsored clinic and has worked for the University of South Florida in medical student education.

Principal Investigator Bradenton Location:

Louis B. Chaykin, MD, - Board certified in Endocrinology. Dr. Louis Chaykin has over 15 years in pharmaceutical research and has been a Principal Investigator with Meridien Research since 2007. He has conducted more than 50 studies in his specialty including diabetes, lipids, metabolic syndrome and osteoporosis. Since joining Meridien Research Dr. Chaykin has broadened his range of investigation to include obesity, women’s health, post herpetic neuralgia and hypertension.

Dr. Chaykin continues to have additional involvement in the medical community. He is a Clinical Associate Professor at the University of Miami School of Medicine and is involved with chairing and developing programs for CME and CEU for Physicians, Nurses, P.A.s, Dieticians, and Pharmacists in Diabetes and related topics. He is a national speaker for Eli Lilly on the topic of relationship of atypical anti-psychotics as they relate to risk of metabolic syndrome, diabetes and cardiovascular events in the treatment of schizophrenia and bi-polar disorders.

Principal Investigator Brooksville Location:

Mildred Farmer, MD is board certified in Internal Medicine and is fellowship trained in Geriatrics. She has been a principal investigator since 1990 for over 500 trials across multiple therapeutic areas. She has particular expertise in cognitive impairment from Age-associated Memory Impairment to Severe Dementia. She has extensive experience in memory, mood disorders, women's health, migraine, smoking cessation, nutrition, geriatrics, and metabolic studies including lipid disorders, diabetes, and hypertension. Dr. Farmer has been audited by the FDA 5 times since 1990 for high enrollment in pivotal trials.

Principal Investigator(s) St Petersburg Location:

Mildred Farmer, MD is board certified in Internal Medicine and is fellowship trained in Geriatrics. She has been a principal investigator since 1990 for over 500 trials across multiple therapeutic areas. She has particular expertise in cognitive impairment from Age-associated Memory Impairment to Severe Dementia. She has extensive experience in memory, mood disorders, women's health, migraine, smoking cessation, nutrition, geriatrics, and metabolic studies including lipid disorders, diabetes, and hypertension. Dr. Farmer has been audited by the FDA 5 times since 1990 for high enrollment in pivotal trials.

Gigi C. Lefebvre, MD – board certified in Family Practice. Gigi C. Lefebvre, MD has been in private practice in St. Petersburg since 1990. She continues to see patients at her private practice as well as serving as Principal Investigator. Dr. Lefebvre has been conducting trials in multi-therapeutic areas with Meridien Research since January of 2006.